Zhou Hua, Wu Fengliang, Dang Lei, Li Yan, Liu Xiaoguang, Liu Zhongjun, Wei Feng
Department of Orthopaedics, Peking University Third Hospital, Beijing, China.
Engineering Research Center of Bone and Joint Precision Medicine, Beijing, China.
Eur Spine J. 2023 Jan;32(1):254-260. doi: 10.1007/s00586-022-07455-w. Epub 2022 Nov 16.
To compare total en bloc spondylectomy with marginal margins against piecemeal spondylectomy with intralesional margins in the surgical treatment of Enneking stage III spinal giant cell tumor (GCT) in terms of local recurrence.
A retrospective survival analysis of patients with Enneking stage III GCT who underwent TES with marginal margins or total piecemeal spondylectomy with intralesional margins was performed between January 2006 and April 2020. Local recurrence-free survival (LRFS) was the time between the date of surgery and recurrence. Factors with p-values < 0.05 in the univariate analysis were included in the multivariate analysis using proportional hazard analysis.
Sixty patients (25 men and 35 women) with a mean age of 35.6 (range 11-71) years were included. The mean follow-up duration was 93 (range 24-198) months. Two patients were lost to follow-up 6 and 14 years after the procedure. Over a 10-year period, the recurrence rate was 13.3%. The 2-, 5-, and 10-year LRFS rates were 95%, 88%, and 78%, respectively. Univariate analysis identified total piecemeal spondylectomy and no adjuvant radiotherapy as prognostic factors for LRFS. Multivariate Cox-regression models showed a significant association between local recurrence and total piecemeal spondylectomy and no adjuvant radiotherapy.
TES with marginal margins is better than total piecemeal spondylectomy with intralesional margins owing to its lower postoperative recurrence rate. Adjuvant radiotherapy should be administered to reduce postoperative recurrence rates.
比较整块切除且切缘为边缘性的全椎体切除术与分块切除且切缘为瘤内的椎体切除术在手术治疗Enneking III期脊柱巨细胞瘤(GCT)时局部复发方面的差异。
对2006年1月至2020年4月期间接受边缘性全椎体切除术(TES)或瘤内分块全椎体切除术的Enneking III期GCT患者进行回顾性生存分析。无局部复发生存期(LRFS)为手术日期至复发的时间。单因素分析中p值<0.05的因素纳入多因素分析,采用比例风险分析。
纳入60例患者(25例男性和35例女性),平均年龄35.6岁(范围11 - 71岁)。平均随访时间为93个月(范围24 - 198个月)。2例患者在术后6年和14年失访。在10年期间,复发率为13.3%。2年、5年和10年的LRFS率分别为95%、88%和78%。单因素分析确定分块全椎体切除术和未行辅助放疗是LRFS的预后因素。多因素Cox回归模型显示局部复发与分块全椎体切除术和未行辅助放疗之间存在显著关联。
由于术后复发率较低,边缘性全椎体切除术优于瘤内分块全椎体切除术。应给予辅助放疗以降低术后复发率。